FDA Inspection
Allergan Sales, LLCAllergan Sales, LLC – FDA Inspection, Feb 27, 2019
Record Details
This FDA Inspection record concerns Allergan Sales, LLC, with an inspection on February 27, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 33a55514-c574-4083-ae1f-d8050a78d708
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1080772
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 211.42(c)(10)(v)Cleaning System
- 21 CFR 211.42(c)(10)(iv)Environmental Monitoring System
- 21 CFR 211.113(b)Procedures for sterile drug products
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Allergan Sales, LLC
9| Date | Classification | Office | Project area |
|---|---|---|---|
| July 31, 2026 | Not classified | Dallas District Office | Drug Quality Assurance |
| March 24, 2022 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 28, 2016 | VAI | Center for Drug Evaluation and Research | New Drug Evaluation |
| October 8, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 10, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Allergan Sales, LLC
- FDA Inspection 1316492 - 2026-07-31
- FDA Inspection 1166865 - 2022-03-24
- FDA Inspection 991999 - 2016-10-28
- FDA Inspection 947137 - 2015-10-08
- FDA Inspection 937479 - 2015-07-10
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.